Litigation Details for Sanofi-Aventis U.S. LLC v. Breckenridge Pharmaceutical, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Sanofi-Aventis U.S. LLC v. Breckenridge Pharmaceutical, Inc. (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-01-05 |
Court | District Court, D. Delaware | Date Terminated | 2017-10-30 |
Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
Jury Demand | None | Referred To | |
Parties | SANOFI | ||
Patents | 6,794,410; 8,802,735; 9,186,346 | ||
Attorneys | Ann C. Palma | ||
Firms | Phillips, McLaughlin & Hall, P.A. | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Sanofi-Aventis U.S. LLC v. Breckenridge Pharmaceutical, Inc.
Details for Sanofi-Aventis U.S. LLC v. Breckenridge Pharmaceutical, Inc. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2017-01-04 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,794,410 C1; US 9,186,346 …2017 30 October 2017 1:17-cv-00019 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |